<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Inflammatory Bowel Disease (Crohn Disease & Ulcerative Colitis) | Family Medicine Reference</title>
  <style>
    body {
      font-family: "Segoe UI", Tahoma, Geneva, Verdana, sans-serif;
      background-color: #f8f9fa;
      color: #212529;
      line-height: 1.6;
      margin: 40px;
    }
    h1, h2, h3 {
      color: #004085;
    }
    section {
      background: #ffffff;
      border-radius: 8px;
      box-shadow: 0 2px 5px rgba(0,0,0,0.1);
      padding: 25px;
      margin-bottom: 20px;
    }
    table {
      width: 100%;
      border-collapse: collapse;
      margin: 10px 0;
    }
    th, td {
      border: 1px solid #dee2e6;
      padding: 10px;
      text-align: left;
    }
    th {
      background-color: #e9ecef;
    }
    .compare {
      display: flex;
      flex-wrap: wrap;
      gap: 20px;
    }
    .column {
      flex: 1;
      min-width: 360px;
      background: #fff;
      border-radius: 8px;
      box-shadow: 0 1px 3px rgba(0,0,0,0.1);
      padding: 20px;
    }
    .source {
      font-size: 0.9em;
      color: #555;
    }
    a {
      color: #0069d9;
      text-decoration: none;
    }
    a:hover {
      text-decoration: underline;
    }
  </style>
</head>
<body>

  <h1>Inflammatory Bowel Disease (IBD)</h1>
  <p>
    Inflammatory bowel disease (IBD) comprises two chronic, relapsing inflammatory conditions of the gastrointestinal tract: 
    <strong>Crohn disease (CD)</strong> and <strong>Ulcerative colitis (UC)</strong>. 
    Both share overlapping features but differ in their distribution, depth of inflammation, and extraintestinal manifestations.
  </p>

  <div class="compare">
    <div class="column">
      <h2>Crohn Disease (CD)</h2>
      <h3>Overview</h3>
      <p>
        Chronic, relapsing inflammatory disorder that can affect any part of the GI tract 
        — from the mouth to the anus — most commonly the terminal ileum and colon.
      </p>

      <h3>Etiology & Pathophysiology</h3>
      <ul>
        <li>Immune dysregulation with inappropriate activation against gut microbiota.</li>
        <li>Genetic predisposition (e.g., NOD2 mutation).</li>
        <li>Environmental triggers: smoking, NSAIDs, infections.</li>
      </ul>

      <h3>Clinical Features</h3>
      <ul>
        <li>Chronic diarrhea (often non-bloody).</li>
        <li>Right lower quadrant abdominal pain.</li>
        <li>Weight loss, fatigue, fever.</li>
        <li>Perianal disease: fistulas, abscesses, fissures.</li>
      </ul>

      <h3>Extraintestinal Manifestations</h3>
      <ul>
        <li><strong>Joints:</strong> arthritis, spondylitis.</li>
        <li><strong>Skin:</strong> erythema nodosum, pyoderma gangrenosum.</li>
        <li><strong>Eyes:</strong> uveitis, episcleritis.</li>
        <li><strong>Hepatobiliary:</strong> cholelithiasis, fatty liver.</li>
        <li><strong>Renal:</strong> nephrolithiasis (calcium oxalate).</li>
      </ul>

      <h3>Diagnosis</h3>
      <ul>
        <li><strong>Colonoscopy:</strong> skip lesions, cobblestone mucosa, deep linear ulcers.</li>
        <li><strong>Histology:</strong> transmural inflammation, granulomas (noncaseating).</li>
        <li><strong>Imaging:</strong> MRE/CTE – bowel wall thickening, fistulas, creeping fat.</li>
        <li><strong>Serology:</strong> ↑ ASCA, pANCA negative.</li>
        <li><strong>Labs:</strong> ↑ CRP, anemia, low B12, iron deficiency.</li>
      </ul>

      <h3>Complications</h3>
      <ul>
        <li>Fistulas (enteroenteric, enterocutaneous).</li>
        <li>Abscess formation.</li>
        <li>Strictures → bowel obstruction.</li>
        <li>Malabsorption and vitamin deficiencies.</li>
        <li>Increased risk of colorectal cancer.</li>
      </ul>

      <h3>Treatment</h3>
      <ul>
        <li><strong>Induction of remission:</strong> corticosteroids (e.g., prednisone, budesonide).</li>
        <li><strong>Maintenance therapy:</strong> immunomodulators (azathioprine, methotrexate), biologics (anti-TNF agents).</li>
        <li><strong>Antibiotics:</strong> for perianal disease or abscesses (ciprofloxacin + metronidazole).</li>
        <li><strong>Surgery:</strong> for strictures, obstruction, or refractory disease (not curative).</li>
      </ul>
    </div>

    <div class="column">
      <h2>Ulcerative Colitis (UC)</h2>
      <h3>Overview</h3>
      <p>
        Chronic inflammatory disease limited to the <strong>colon and rectum</strong>, 
        characterized by continuous mucosal inflammation starting in the rectum and extending proximally.
      </p>

      <h3>Etiology & Pathophysiology</h3>
      <ul>
        <li>Autoimmune-mediated mucosal inflammation limited to the large intestine.</li>
        <li>Triggered by gut flora imbalance, infections, and immune dysregulation.</li>
        <li>Smoking is protective (unlike Crohn disease).</li>
      </ul>

      <h3>Clinical Features</h3>
      <ul>
        <li>Bloody diarrhea with mucus.</li>
        <li>Fecal urgency and tenesmus.</li>
        <li>Lower abdominal pain relieved by defecation.</li>
        <li>Systemic symptoms: fatigue, low-grade fever.</li>
      </ul>

      <h3>Extraintestinal Manifestations</h3>
      <ul>
        <li><strong>Joints:</strong> arthritis, sacroiliitis, ankylosing spondylitis.</li>
        <li><strong>Skin:</strong> erythema nodosum, pyoderma gangrenosum.</li>
        <li><strong>Eyes:</strong> uveitis, iritis, episcleritis.</li>
        <li><strong>Hepatobiliary:</strong> primary sclerosing cholangitis (PSC).</li>
      </ul>

      <h3>Diagnosis</h3>
      <ul>
        <li><strong>Colonoscopy:</strong> continuous lesions, friable mucosa, loss of vascular pattern, ulcerations.</li>
        <li><strong>Histology:</strong> mucosal and submucosal inflammation, crypt abscesses.</li>
        <li><strong>Serology:</strong> ↑ pANCA, ASCA negative.</li>
        <li><strong>Labs:</strong> ↑ ESR/CRP, anemia, hypoalbuminemia.</li>
      </ul>

      <h3>Complications</h3>
      <ul>
        <li>Toxic megacolon.</li>
        <li>Massive bleeding.</li>
        <li>Perforation.</li>
        <li>Colorectal carcinoma (risk increases after 8–10 years).</li>
      </ul>

      <h3>Treatment</h3>
      <ul>
        <li><strong>Mild–moderate:</strong> 5-ASA agents (mesalamine oral or rectal).</li>
        <li><strong>Moderate–severe:</strong> corticosteroids for induction, then immunomodulators (azathioprine, 6-MP) or biologics.</li>
        <li><strong>Refractory/complicated:</strong> colectomy is curative.</li>
      </ul>
    </div>
  </div>

  <section>
    <h2>Comparison Summary</h2>
    <table>
      <tr><th>Feature</th><th>Crohn Disease</th><th>Ulcerative Colitis</th></tr>
      <tr><td>Distribution</td><td>Mouth to anus (skip lesions)</td><td>Rectum → colon (continuous)</td></tr>
      <tr><td>Depth of inflammation</td><td>Transmural</td><td>Mucosal and submucosal</td></tr>
      <tr><td>Common site</td><td>Terminal ileum</td><td>Rectum and sigmoid colon</td></tr>
      <tr><td>Rectal involvement</td><td>Uncommon</td><td>Always</td></tr>
      <tr><td>Bleeding</td><td>Less common</td><td>Common, bloody diarrhea</td></tr>
      <tr><td>Smoking</td><td>Worsens disease</td><td>Protective</td></tr>
      <tr><td>Fistulas/Strictures</td><td>Common</td><td>Rare</td></tr>
      <tr><td>PSC association</td><td>Rare</td><td>Common</td></tr>
      <tr><td>Malignancy risk</td><td>Increased (esp. colonic involvement)</td><td>High (after years of disease)</td></tr>
      <tr><td>Curative surgery</td><td>No</td><td>Yes (colectomy)</td></tr>
    </table>
  </section>

  <p class="source">
    Sources:  
    <br>
    <a href="https://www.amboss.com/us/knowledge/crohn-disease?utm_medium=chatgpt-plugin&utm_source=chatgpt" target="_blank">AMBOSS: Crohn Disease</a>  
    <br>
    <a href="https://www.amboss.com/us/knowledge/ulcerative-colitis?utm_medium=chatgpt-plugin&utm_source=chatgpt" target="_blank">AMBOSS: Ulcerative Colitis</a>
  </p>

</body>
</html>
